These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 35875396)

  • 1. Fractional CO2 laser and adjunctive therapies in skin of color melasma patients.
    Kim C; Gao JC; Moy J; Lee HS
    JAAD Int; 2022 Sep; 8():118-123. PubMed ID: 35875396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intradermal injection of tranexamic acid versus platelet-rich plasma in the treatment of melasma: a split-face comparative study.
    Abd Elraouf IG; Obaid ZM; Fouda I
    Arch Dermatol Res; 2023 Aug; 315(6):1763-1770. PubMed ID: 36856856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized, open-label study to compare two different dosing regimens of oral tranexamic acid in treatment of moderate to severe facial melasma.
    Bhattacharjee R; Hanumanthu V; Thakur V; Bishnoi A; Vinay K; Kumar A; Parsad D; Kumaran MS
    Arch Dermatol Res; 2023 Aug; 315(6):1831-1836. PubMed ID: 36757440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic efficiency and safety assessment of intradermal platelet-rich plasma combined with oral tranexamic acid in patients with facial melasma.
    Tawanwongsri W; Siri-Archawawat D; Sindhusen S; Eden C
    Adv Clin Exp Med; 2024 Jun; ():. PubMed ID: 38934336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and Safety of Ablative Fractional Laser in Melasma: A Meta-analysis and Systematic Review.
    Zhao S; Wang M; Lai X; Yan Y
    Lasers Med Sci; 2024 Feb; 39(1):71. PubMed ID: 38379033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Intense Pulsed Light versus Intradermal Tranexamic Acid for the Management of Melasma.
    Asim SA; Iqbal T; Sajid M; Bhatti S
    J Coll Physicians Surg Pak; 2024 May; 34(5):522-526. PubMed ID: 38720210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Melasma treatment with a 1064 nm, picosecond-domain laser with a fractionated multibeam lens array.
    Bernstein EF; Basilavecchio LD; Wang J
    Lasers Surg Med; 2023 Nov; 55(9):801-808. PubMed ID: 37668307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Definition of refractory melasma and its treatment: a review.
    Yao H; Shen S; Gao X; Feng J; Song X; Xiang W
    Lasers Med Sci; 2024 Apr; 39(1):118. PubMed ID: 38679674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the effectiveness of microneedling with tranexamic acid in comparison with microneedling with vitamin C in the treatment of melasma: A prospective and single-blind clinical trial.
    Pazyar N; Raeispour M; Yaghoobi R; Seyedtabib M
    Health Sci Rep; 2023 Oct; 6(10):e1636. PubMed ID: 37867785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing the efficacy of oral Tranexamic Acid as adjuvant of Topic Triple Combination Cream Therapy in Melasma: A Meta-Analysis of Randomized Controlled Trials.
    Ribeiro Gonçalves O; de Souza MCF; Rocha AV; Alves GS; Freitas JLR; de Azevedo BB; Sobral MVS; Handocha AS; Baima de Melo C
    Clin Exp Dermatol; 2024 Jun; ():. PubMed ID: 38848545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Energy-Based Devices for the Treatment of Facial Skin Conditions in Skin of Color.
    Sanyal RD; Fabi SG
    J Clin Aesthet Dermatol; 2024 Jun; 17(6):22-32. PubMed ID: 38912197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of mesotherapy with tranexamic acid versus vitamin C in the treatment of melasma: A meta-analysis and systemic review.
    Liao X; Cheng F; Jiang Y
    J Cosmet Dermatol; 2024 May; ():. PubMed ID: 38693699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Melasma: A Step-by-Step Approach Towards a Multimodal Combination Therapy.
    Philipp-Dormston WG
    Clin Cosmet Investig Dermatol; 2024; 17():1203-1216. PubMed ID: 38800358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral Tranexamic Acid for the Treatment of Melasma: Evidence and Experience-Based Consensus Statement from Indian Experts.
    Godse K; Sarkar R; Mysore V; Shenoy MM; Chatterjee M; Damisetty R; Shah S; Vedamurthy M; Aurangabadkar S; Srinivas C; Ganjoo A; Das S; Patil A
    Indian J Dermatol; 2023; 68(2):178-185. PubMed ID: 37275826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral tranexamic acid treatment beyond 6 months for melasma patients - A retrospective case series.
    Lam K; Mansour D; Sutton A
    JAAD Int; 2024 Jun; 15():195-196. PubMed ID: 38707929
    [No Abstract]   [Full Text] [Related]  

  • 16. A case-control study of racial differences in melasma risk factors and incidence in a diverse national United States population.
    Getachew ED; Kamal K; Young K; Xiang DH; Semenov Y; Mostaghimi A; Theodosakis N
    J Am Acad Dermatol; 2024 May; ():. PubMed ID: 38729433
    [No Abstract]   [Full Text] [Related]  

  • 17. Energy-based devices in the treatment of acne scars in skin of color.
    Teymour S; Kania B; Lal K; Goldberg D
    J Cosmet Dermatol; 2023 Apr; 22(4):1177-1184. PubMed ID: 36575886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of picosecond laser for the treatment of melasma: a systematic review and meta-analysis.
    Feng J; Shen S; Song X; Xiang W
    Lasers Med Sci; 2023 Mar; 38(1):84. PubMed ID: 36897459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review of Laser Treatments for Post-Inflammatory Hyperpigmentation in Skin of Color.
    Sowash M; Alster T
    Am J Clin Dermatol; 2023 May; 24(3):381-396. PubMed ID: 36781686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Understanding Melasma-How Can Pharmacology and Cosmetology Procedures and Prevention Help to Achieve Optimal Treatment Results? A Narrative Review.
    Piętowska Z; Nowicka D; Szepietowski JC
    Int J Environ Res Public Health; 2022 Sep; 19(19):. PubMed ID: 36231404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.